Stress, craving and mood as predictors of early dropout from opioid agonist therapy
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: Treatment with opioid agonists is effective for opioid use disorder, but early discontinuation of treatment is a major obstacle to success. Intensive longitudinal methods — which take many repeated measurements over time, usually in the field— have provided unique insight into the effects of stress, mood and craving on drug use while people are being treated; these methods might also be useful for studying the processes that lead people to drop out of treatment. Methods: Ecological momentary assessment (EMA) was conducted for up to 17 weeks by obtaining multiple electronic diary entries per day from 238 participants being treated with methadone or buprenorphine-naloxone. Survival analysis was used to study two outcomes: dropping out of treatment and noncompliance with EMA self-report requirements. Self-reports of stress, craving, and mood were used as time-varying predictors. Demographic and psychosocial variables measured with the Addiction Severity Index at the start of treatment were used as time-invariant predictors. Results: Dropping out of treatment was more likely in participants with more reported hassles (a measure of stress), higher levels of cocaine craving, lower levels of positive mood, a recent history of emotional abuse, a recent history of being bothered frequently by psychological problems, and with buprenorphine rather than methadone as their medication. In contrast, study noncompliance was not significantly associated with any of the variables analyzed. Conclusions: Assessment of stress, craving and mood during treatment might identify people who are at greater risk of dropping out, and therapeutic interventions targeting these processes might increase retention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ecological momentary assessment
Shiffman, S., Stone, A. A., & Hufford, M. R. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091415 · Cited by 6,454
New Data from the Addiction Severity Index Reliability and Validity in Three Centers
McLELLAN, A. T., LUBORSKY, L., CACCIOLA, J., GRIFFITH, J., EVANS, F., BARR, H. L., & OʼBRIEN, C. P. (1985) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198507000-00005 · Cited by 1,503 · cited 9×
“During a screening session, each participant completed the Addiction Severity Index (ASI) (McLellan et al., 1985), a semi-structured interview covering a wide range of psychosocial variables.”
MethodInfluentialHealthcare via Cell Phones: A Systematic Review
Krishna, S., Boren, S. A., & Balas, E. A. (2009) · Telemedicine and e-Health · doi:10.1089/tmj.2008.0099 · Cited by 882
Drop-out from addiction treatment: A systematic review of risk factors
Brorson, H. H., Ajo Arnevik, E., Rand-Hendriksen, K., & Duckert, F. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2013.07.007 · Cited by 654
Contrasts and Correlations in Effect-Size Estimation
Rosnow, R. L., Rosenthal, R., & Rubin, D. B. (2000) · Psychological Science · doi:10.1111/1467-9280.00287 · Cited by 513
Maintenance Medication for Opiate Addiction: The Foundation of Recovery
Bart, G. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.694598 · Cited by 461 · cited 2×
“…methadone and buprenorphine are considered to be the best available treatments (Mattick et al., 2014; Volkow et al., 2014); they can decrease mortality, drug use, drug craving, and criminal activity (Bart, 2012; Salsitz and Wiegand, 2016) and increase quality of life (Mitchell et al., 2015).”
BackgroundHser, Y., Saxon, A. J., Huang, D., Hasson, A., Thomas, C., Hillhouse, M., Jacobs, P., Teruya, C., McLaughlin, P., Wiest, K., et al. (2014) · Addiction · doi:10.1111/add.12333 · Cited by 455 · cited 4×
“As in many earlier studies (Gerra et al., 2004; Gryczynski et al., 2013; Hser et al., 2014; Mattick et al., 2014), the dropout rate was higher for participants treated with buprenorphine (a partial μ-opioid agonist) than for those treated with methadone (a full μ-opioid agonist).”
BackgroundResultInfluentialDobkin, P. L., Civita, M. D., Paraherakis, A., & Gill, K. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00083.x · Cited by 378
The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review
Carroll, K. M., & Weiss, R. D. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16070792 · Cited by 211 · cited 1×
“In a recent review of behavioral interventions that have been tested in combination with buprenorphine treatment, contingency management emerged as the one type of intervention that was effective at improving outcome (Carroll and Weiss, 2017).”
BackgroundKowalczyk, W. J., Phillips, K. A., Jobes, M. L., Kennedy, A. P., Ghitza, U. E., Agage, D. A., Schmittner, J. P., Epstein, D. H., & Preston, K. L. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14081014 · Cited by 101 · cited 1×
“We have shown that clonidine, given during opioid maintenance rather than taper, decreased stress-induced craving and delayed relapse to drug use, but it did not reduce the level of dropout (Kowalczyk et al., 2015; see also Weinstein et al., 2017).”
BackgroundSelf-citation
Cited by
Retention of patients in opioid substitution treatment: A systematic review
O’Connor, A. M., Cousins, G., Durand, L., Barry, J., & Boland, F. (2020) · PLOS ONE · doi:10.1371/journal.pone.0232086 · Cited by 298
(2021) · Journal of Behavioral Addictions · doi:10.1556/2006.2021.00070 · Cited by 47
Do out-of-pocket costs influence retention and adherence to medications for opioid use disorder?
Dunphy, C., Peterson, C., Zhang, K., & Jones, C. M. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108784 · Cited by 41
Rosansky, J. A., Howard, L., Goodman, H., Okst, K., Fatkin, T., Fredericksen, A. K., Sokol, R., Gardiner, P., Parry, G., Cook, B. L., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107417 · Cited by 3
Metadata
- Authors
- Panlilio, L. V., Stull, S. W., Kowalczyk, W. J., Phillips, K. A., Schroeder, J. R., Bertz, J. W., Vahabzadeh, M., Lin, J.-L., Mezghanni, M., Nunes, E. V., Epstein, D. H., & Preston, K. L.
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 202
- Pages
- 200-208
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2958946344
- Cited by
- 99
- References
- 17
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stress, craving and mood as predictors of early dropout from opioid agonist therapy. https://app.cochat.ai/papers/10.1016/j.drugalcdep.2019.05.026
- The paper
- Panlilio, L. V., Stull, S. W., Kowalczyk, W. J., Phillips, K. A., Schroeder, J. R., Bertz, J. W., Vahabzadeh, M., Lin, J.-L., Mezghanni, M., Nunes, E. V., Epstein, D. H., & Preston, K. L. (2019). Stress, craving and mood as predictors of early dropout from opioid agonist therapy. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2019.05.026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.